|
|
| Research article summary (published 29 Apr 2008): |
Exenatide and rare adverse events.
Full Abstract
No abstract is currently available for this article. See 'Journal and Publication Information' further down the page for details that may assist you in locating this article in electronic or hard copy media. The 'Related articles' section also further down the page, where available, may show links to abstracts of articles covering similar topics.
Author information
Author/s: Cure, Pablo (P); Pileggi, Antonello (A); Alejandro, Rodolfo (R);
Journal and publication information
Publication Type: Letter
Journal: The New England journal of medicine (N Engl J Med), published in United States. (Language: eng)
Reference: 2008-May; vol 358 (issue 18) : pp 1969-70; discussion 1971-2
Dates: Created 2008/05/02; Completed 2008/05/09;
PMID: 18450614, status: MEDLINE (last retrieved date: 2/18/2009)
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MeSH Headings (categories) shown below.
Note: Bold headings indicate primary MeSH headings or qualifiers.
Associated Chemicals: Hypoglycemic Agents (0) ; Peptides (0) ; Venoms (0) ; exenatide (141732-76-5) ; Glucagon-Like Peptide 1 (89750-14-1)Related articles
These are the most related articles currently in our database:
- Exenatide and rare adverse events.
29 Apr 2008 - [Glucagon-like peptide 1 (GLP-1)]
19 Jun 2007 - Missing the point: substituting exenatide for nonoptimized insulin: going from bad to worse!
30 Oct 2007 - Long-acting GLP-1 analogs for the treatment of type 2 diabetes mellitus.
30 Dec 2007 - [Blood sugar and pounds down, hardly hypoglycemias. New generation of antidiabetics ante portas]
29 Aug 2006 - Investigational treatments for Type 2 diabetes mellitus: exenatide and liraglutide.
30 Jul 2006 - Diabetic gastroparesis.
24 Jul 2007 - Beyond glycemic control: the role of incretin hormones.
30 Dec 2006 - [Exenatid and its position as antidiabetic drug in the treatment of type 2 diabetes mellitus]
30 Mar 2008 - [Exenatide (Byetta)]
28 Feb 2008
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a larger map of 100+ related articles.